Mylan releases generic of Vfend
Mylan Pharmaceuticals Inc. has launched voriconazole for oral suspension (40 mg/ml), an antifungal medicine. Mylan said Monday that its product is the first generic version of Pfizer’s Vfend for Oral Suspension. Voriconazole for oral suspension (40 mg/ml), a triazole antifungal drug, had U.S.